Daniel Arber to Leukemia
This is a "connection" page, showing publications Daniel Arber has written about Leukemia.
Connection Strength
5.680
-
Advances in the Classification of Myeloid and Lymphoid Neoplasms. Virchows Arch. 2023 01; 482(1):1-9.
Score: 0.755
-
International Consensus Classification of Myeloid Neoplasms and Acute Leukemias: integrating morphologic, clinical, and genomic data. Blood. 2022 09 15; 140(11):1200-1228.
Score: 0.740
-
How I Diagnose Acute Leukemia of Ambiguous Lineage. Am J Clin Pathol. 2022 07 01; 158(1):27-34.
Score: 0.729
-
Clinical, immunophenotypic, and genomic findings of acute undifferentiated leukemia and comparison to acute myeloid leukemia with minimal differentiation: a study from the bone marrow pathology group. Mod Pathol. 2019 09; 32(9):1373-1385.
Score: 0.584
-
Initial Diagnostic Workup of Acute Leukemia: Guideline From the College of American Pathologists and the American Society of Hematology. Arch Pathol Lab Med. 2017 Oct; 141(10):1342-1393.
Score: 0.503
-
Mixed-phenotype acute leukemia: historical overview and a new definition. Leukemia. 2010 Nov; 24(11):1844-51.
Score: 0.322
-
The international consensus classification of eosinophilic disorders and systemic mastocytosis. Am J Hematol. 2023 08; 98(8):1286-1306.
Score: 0.195
-
The International Consensus Classification of acute leukemias of ambiguous lineage. Blood. 2023 05 04; 141(18):2275-2277.
Score: 0.193
-
The international consensus classification of myeloid neoplasms and acute Leukemias: myeloproliferative neoplasms. Am J Hematol. 2023 01; 98(1):166-179.
Score: 0.186
-
B-cell lymphoma-2 downregulation is a useful feature supporting a neoplastic phenotype in mature T-cell lymphomas. Hum Pathol. 2022 07; 125:48-58.
Score: 0.180
-
Diagnostic utility of bilateral bone marrow examination: significance of morphologic and ancillary technique study in malignancy. Cancer. 2002 Mar 01; 94(5):1522-31.
Score: 0.178
-
Evaluation of T cell receptor testing in lymphoid neoplasms: results of a multicenter study of 29 extracted DNA and paraffin-embedded samples. J Mol Diagn. 2001 Nov; 3(4):133-40.
Score: 0.174
-
CD79: a review. Appl Immunohistochem Mol Morphol. 2001 Jun; 9(2):97-106.
Score: 0.169
-
Initial Diagnostic Work-Up of Acute Leukemia: ASCO Clinical Practice Guideline Endorsement of the College of American Pathologists and American Society of Hematology Guideline. J Clin Oncol. 2019 01 20; 37(3):239-253.
Score: 0.142
-
Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome. Haematologica. 2017 08; 102(8):1352-1360.
Score: 0.128
-
Paraffin section immunophenotyping of acute leukemias in bone marrow specimens. Am J Clin Pathol. 1996 Oct; 106(4):462-8.
Score: 0.122
-
Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified. Mod Pathol. 2016 08; 29(8):854-64.
Score: 0.119
-
Clinical activity of ponatinib in a patient with FGFR1-rearranged mixed-phenotype acute leukemia. Leukemia. 2016 Apr; 30(4):947-50.
Score: 0.112
-
The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. 2009 Jul 30; 114(5):937-51.
Score: 0.073
-
Predictors of therapy-related leukemia and myelodysplasia following autologous transplantation for lymphoma: an assessment of risk factors. Blood. 2000 Mar 01; 95(5):1588-93.
Score: 0.039
-
Practical applications of immunohistochemistry in hematolymphoid neoplasms. Ann Diagn Pathol. 1999 Apr; 3(2):104-33.
Score: 0.036